Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy M Frech

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Arthritis Care & Research|October 10, 2022
Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short-Form DevelopmentLan Yu, Robyn T Domsic, Lesley-Ann Saketkoo, et al.
Journal of Scleroderma and Related Disorders|September 29, 2025
Criteria for defining and dating onset of organ system involvement in systemic sclerosisMarie Hudson, John D Pauling, Tatiana S Rodriguez-Reyna, et al.
Rheumatology (Oxford, England)|July 23, 2023
Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaireJohn D Pauling, Lan Yu, Tracy M Frech, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2024
EphB2 Receptor Promotes Dermal Fibrosis in Systemic SclerosisErika S A Egal, Severin Donald Kamdem, Masaaki Yoshigi, et al.
Disability and Rehabilitation|March 20, 2020
Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique studySami Harb, Julie Cumin, Danielle B Rice, et al.
Rheumatology (Oxford, England)|May 22, 2026
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosisMatthew Wells, Theresa Smith, Robyn T Domsic, et al.
Rheumatology (Oxford, England)|February 8, 2020
Patient experiences of digital ulcer development and evolution in systemic sclerosisMichael Hughes, John D Pauling, Jennifer Jones, et al.
Arthritis Care & Research|December 17, 2019
Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic SclerosisMichael Hughes, John D Pauling, Jennifer Jones, et al.
Clinical and Experimental Rheumatology|July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationaleRobert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
The Journal of Rheumatology|March 17, 2017
Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis CohortJessica K Gordon, Gandikota Girish, Veronica J Berrocal, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Arthritis Care & Research|October 10, 2022
Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short-Form DevelopmentLan Yu, Robyn T Domsic, Lesley-Ann Saketkoo, et al.
Journal of Scleroderma and Related Disorders|September 29, 2025
Criteria for defining and dating onset of organ system involvement in systemic sclerosisMarie Hudson, John D Pauling, Tatiana S Rodriguez-Reyna, et al.
Rheumatology (Oxford, England)|July 23, 2023
Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaireJohn D Pauling, Lan Yu, Tracy M Frech, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2024
EphB2 Receptor Promotes Dermal Fibrosis in Systemic SclerosisErika S A Egal, Severin Donald Kamdem, Masaaki Yoshigi, et al.
Disability and Rehabilitation|March 20, 2020
Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique studySami Harb, Julie Cumin, Danielle B Rice, et al.
Rheumatology (Oxford, England)|May 22, 2026
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosisMatthew Wells, Theresa Smith, Robyn T Domsic, et al.
Rheumatology (Oxford, England)|February 8, 2020
Patient experiences of digital ulcer development and evolution in systemic sclerosisMichael Hughes, John D Pauling, Jennifer Jones, et al.
Arthritis Care & Research|December 17, 2019
Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic SclerosisMichael Hughes, John D Pauling, Jennifer Jones, et al.
Clinical and Experimental Rheumatology|July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationaleRobert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
The Journal of Rheumatology|March 17, 2017
Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis CohortJessica K Gordon, Gandikota Girish, Veronica J Berrocal, et al.
Pageof 11